ClinicalTrials.govpublic full text
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
hpv infections, cervical cancer, vulvar cancer, vaginal cancer, cin1, cin2, cin 3, vain1, vain2, vain3, genital wart, vin 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1008367
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.